Hiromichi Kimura

After receiving his Ph.D. in pharmaceutical sciences from the University of Tokyo in 1979, Dr. Kimura started his career as a manager responsible for clinical trials and new drug approval at the pharmaceutical division of Kyowa Hakko Kogyo in Tokyo. He was selected to attend the Graduate School of Business at Stanford University, where he received an MBA in Management and International Business. After returning to Japan, he became a manager responsible for licensing and strategic alliances with foreign pharmaceutical and biotechnology companies.
In 1986 Dr. Kimura joined J.P. Morgan as Vice President, Financial Advisory and Mergers & Acquisitions Division, Tokyo and New York with responsibility for cross-border M&A transactions in the pharmaceutical, high- tech and chemical industries as well as industry analysis within the pharmaceutical industry.
Dr. Kimura joined Pharmacia K.K. in 1989 as Executive Vice President, a member of the Board of Directors and Biotech Division Head. In 1993 he became President and CEO of Pharmacia Biotech K.K., and President and CEO of Amersham Pharmacia Biotech K.K. in 1997. From 1998 to 2000, Dr. Kimura was the President and CEO of Monsanto Japan Ltd.
He founded his own consulting firm, Life Science Management Inc., in 2000 and a life science / healthcare venture capital firm, Fast Track Initiative Inc., in 2004. He serves as President and Chief Executive Officer of both firms today.
In 2002, Dr. Kimura was appointed as a Project Professor of the University of Tokyo, and became a Visiting Professor in 2016.
He is also a Project Leader of Center of Open Innovation Network for Smart Health (COINS), The Center of Innovation (COI) Program, and a trustee of Keizai Doyukai (Japan Association of Corporate Executives) and the director of Stanford Alumni Association in Japan.